Carolinas Medical Center, Charlotte, U.S.
Acute coronary syndromes in low-risk patients are not effectively ruled out by multimarker panel
Published in Nursing Home and Elder Business Week, September 17th, 2006
According to recent research published in the journal Academic Emergency Medicine, investigators aimed "to test novel markers of acute coronary syndrome (ACS), monocyte chemoattractant protein-1(MCP), myeloperoxidase (MPO), C-reactive protein (CRP), and brain natriuretic peptide (BNP) in low-risk emergency department (ED) patients who were evaluated for ACS in a chest pain unit (CPU)."
"A convenience sample of 414 patients underwent CPU evaluation, including provocative testing, and were followed prospectively for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Nursing Home and Elder Business Week
More Articles from Nursing Home and Elder Business Week
- Finance
AmeriPath reports 33.5% increase in net revenues - Fitch Ratings
Fitch upgrades Valley View Hospital (Oklahoma) to 'BBB+'; removes from Rating Watch Negative - Hospira
Hospira names Thomas E. Werner as CFO - Johns Hopkins University, U.S.
Researchers from the United States and South Korea provide details of new studies and findings in the area of heart disease - Malmo University Hospital, Malmo, Sweden
Studies from Sweden, the United States and the South Korea advance knowledge in breast cancer research - McMaster University, Canada
Cost-effectiveness of osteoporosis treatments were compared - More from this issue of Nursing Home and Elder Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
